Search - tctmd.com

Displaying 81 - 100 of 106

Sort: Relevancy | Date

News Daily News

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

L.A. McKeown

March 28, 2019

Presentation CIT 2019

Practical Considerations for Long DAPT Based on Lesion and Patient Selections

Presenter: Tullio Palmerini

March 28, 2019

Presentation SIF 2019

Pharmacologic Strategies for Managing Patients with Atrial Fibrillation Undergoing Coronary Intervention

Presenter: Michael A. Kutcher

March 28, 2019

Presentation SIF 2019

DAPT Duration and When to Switch to Antiplatelet Monotherapy Post PCI

Presenter: Michael A. Kutcher

March 28, 2019

News Conference News ACC 2019

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Yael L. Maxwell

March 27, 2019

News Conference News ACC 2019

Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI

Yael L. Maxwell

March 18, 2019

News Opinion Editor's Corner ACC 2019

Live From New Orleans: Days 2 and 3 at ACC 2019

Shelley Wood

March 18, 2019

News Daily News

COMPASS Published: Experts See Level I Evidence in Support of Aspiration Thrombectomy for Stroke

Todd Neale

March 14, 2019

News Conference News CRT 2019

Rivaroxaban in Addition to DAPT Lowers Death, MI, Stroke in ACS, Heart Failure Patients: Meta-analysis

Yael L. Maxwell

March 03, 2019

Presentation JIM 2019

Iatrogenic aortocoronary dissection after routine PCI

Presenter: Pamela Gatto

February 15, 2019

News Conference News ISC 2019

Cilostazol-Based DAPT Safe, Effective in Patients at High Risk for Recurrent Stroke

Todd Neale

February 12, 2019

News Daily News

Sex Disparities Seen in China for Patients With ACS

Todd Neale

January 23, 2019

Podcast

DAPT STEMI, MITRAL, Gender Disparities in Trial Design, and More

January 16, 2019

News Daily News

Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests

L.A. McKeown

January 08, 2019

Presentation Cardiovascular Interventions 2018

DAPT in Evolution: 2018

Presenter: Dean J. Kereiakes

October 26, 2018

CME

Updates on Onyx ONE

Partner Content

SYNERGY-BP-DES-Optimizing Antiplatelet Therapy After PCI in Complex and High Bleeding Risk Patients - Boston Scientific

November 15, 2019

Video

» Topical Discussion

SYNERGY BP-DES & Optimizing Antiplatelet Therapy after PCI in High-Bleeding Risk Patients

October 8, 2019

Video

» Topical Discussion

STOPDAPT 2 HBR – Global Experts Panel Discussion

September 27, 2019

Video

» Topical Discussion

STOPDAPT 2 – Global Experts Discuss the Results and Implications of Landmark Short DAPT Study

June 6, 2019

Advertisement

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

Practical Considerations for Long DAPT Based on Lesion and Patient Selections

Pharmacologic Strategies for Managing Patients with Atrial Fibrillation Undergoing Coronary Intervention

DAPT Duration and When to Switch to Antiplatelet Monotherapy Post PCI

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI

Live From New Orleans: Days 2 and 3 at ACC 2019

COMPASS Published: Experts See Level I Evidence in Support of Aspiration Thrombectomy for Stroke

Rivaroxaban in Addition to DAPT Lowers Death, MI, Stroke in ACS, Heart Failure Patients: Meta-analysis

Iatrogenic aortocoronary dissection after routine PCI

Cilostazol-Based DAPT Safe, Effective in Patients at High Risk for Recurrent Stroke

Sex Disparities Seen in China for Patients With ACS

DAPT STEMI, MITRAL, Gender Disparities in Trial Design, and More

Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests

DAPT in Evolution: 2018

Updates on Onyx ONE

SYNERGY-BP-DES-Optimizing Antiplatelet Therapy After PCI in Complex and High Bleeding Risk Patients - Boston Scientific

SYNERGY BP-DES & Optimizing Antiplatelet Therapy after PCI in High-Bleeding Risk Patients

STOPDAPT 2 HBR – Global Experts Panel Discussion

STOPDAPT 2 – Global Experts Discuss the Results and Implications of Landmark Short DAPT Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content